Status:
UNKNOWN
COVID-19 Related Lockdown Effects On Chronic Diseases
Lead Sponsor:
Centre Hospitalier Universitaire Dijon
Conditions:
Chronic Coronary Syndrome
Heart Failure
Eligibility:
All Genders
9+ years
Brief Summary
The containment associated with the VIDOC-19 pandemic creates an unprecedented societal situation of physical and social isolation. Our hypothesis is that in patients with chronic diseases, confinemen...
Eligibility Criteria
Inclusion
- patients with one of the following chronic diseases: chronic coronary syndrome, heart failure, multiple sclerosis, Horton's disease, AMD, malignant haemopathy, chronic respiratory failure (idiopathic fibrosis, PAH, haemophilia) and already registered in one of the 8 Burgundian registries/cohorts.
Exclusion
- deceased patient, patient cannot be reached after \>3 telephone calls, patient or caregiver does not speak French to carry out telephone interviews
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 7 2021
Estimated Enrollment :
1200 Patients enrolled
Trial Details
Trial ID
NCT04390126
Start Date
April 20 2020
End Date
November 7 2021
Last Update
January 20 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU Dijon Bourgogne
Dijon, France, 21079